N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline
C33H34N2 — CID 153345248
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline
N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline (PubChem CID 153345248) has the molecular formula C33H34N2 and a molecular weight of 458.65 g/mol. Its IUPAC name is N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline.
Molecular Properties
| Compound Name | N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline |
|---|---|
| PubChem CID | 153345248 |
| Molecular Formula | C33H34N2 |
| Molecular Weight | 458.65 g/mol |
| Exact Mass | 458.27 |
| IUPAC Name | N-[(6-naphthalen-1-yl-2-pyridinyl)-(5-propan-2-ylcyclopenta-1,4-dien-1-yl)methyl]-2-propan-2-ylaniline |
| SMILES | CC(C)C1=CCC=C1C(Nc1ccccc1C(C)C)c1cccc(-c2cccc3ccccc23)n1 |
| InChI | InChI=1S/C33H34N2/c1-22(2)25-16-10-18-29(25)33(35-30-19-8-7-14-26(30)23(3)4)32-21-11-20-31(34-32)28-17-9-13-24-12-5-6-15-27(24)28/h5-9,11-23,33,35H,10H2,1-4H3 |
| InChIKey | DXMGWQDPAUSIJL-UHFFFAOYSA-N |
| XLogP | 9.09 |
| TPSA | 24.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.65 |
| LogP ≤ 5 | 9.09 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153345248 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.